| Overview |
| bsm-90311r-50µL |
| Ephrin Receptor B4 Recombinant Antbody Kit (KD-Validated) |
| WB, IC |
| Knockdown Validated |
| Human, Mouse, Rat |
| Specifications |
| Unconjugated |
| Rabbit |
| A synthesized peptide derived from human Eph receptor B4/HTK |
| 5-22/987 |
| Recombinant |
| IgG |
| Lot dependent |
| Affinity Purified |
| 0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
| -20 °C |
| Target |
| 2050 |
| P54760 |
| EPH Receptor B4; Ephrin Receptor EphB4; HTK; Ephrin Type-B Receptor; MYK1; Soluble EPHB4 Variant 1; Hepatoma Transmembrane Kinase; Soluble EPHB4 Variant 2; Tyrosine-Protein Kinase TYRO11; Soluble EPHB4 Variant 3; TYRO11; Tyrosine-Protein Kinase Receptor HTK; EC 2.7.10.1; EC 2.7.10; EphB4 |
| Cell Line: HeLa Knockdown technology: shRNA Knockdown |
| Application Dilution |
| WB |
1:300-5000 |
| IC |
1:1000 |